Webinar information
Note: Blueprint Genetics does not offer Proactive Screening products in the US at this time
If you are having trouble viewing the webinar video, please try clearing your browser’s cookies/cache.
Proactive screening tests typically contain a selection of genes that are associated with autosomal dominant, autosomal recessive, and X-linked conditions. This is inclusive of genes linked to genetic conditions identified as medically actionable by the American College of Medical Genetics and Genomics (ACMG) such as cancer, cardiovascular, and metabolic conditions where early identification may have a treatment that can improve outcomes.
In this webinar, Lotta Koskinen, PhD, and Torry Howell, MS, CGS will discuss how genetic testing can give healthy individuals, without a family history, information about their chance of having a genetic condition.
Webinar Objectives:
- Introduce proactive genetic screening and points to consider when choosing a test and performing laboratory
- Outline topics for pre-and post-test counseling related to genetic screening
- Review experiences with proactive screening through case examples
Unable to attend live? By registering, you will receive a link to a recording of the webinar to watch at your convenience.
Speakers
Lotta Koskinen
Lotta Koskinen is an associate laboratory director with a focus on production and scientific activities. She collaborates with laboratory and genetics directors, and managers and leads in maintaining and developing variant assessment and reporting processes. She also helps to plan and introduce new products. She also coordinates scientific support for Clinical Genomic Services (CGS) and Client Services in their questions related interpretation and reports. Lotta has MSc degree in genetics and received her PhD in medical genetics from the University of Helsinki, Finland in 2009. After post-doctoral training in academic genetics laboratories, she joined Blueprint Genetics in 2017. Prior to her current position, she worked as a geneticist in panel and WES interpretation, and as a manager in the Clinical Interpretation Team at Blueprint Genetics.
Torry Howell
Torry Howell, MS, CGC is a clinical genomic liaison at Blueprint Genetics. She received her Bachelor of Science in Biology from Boston College in Boston, Massachusetts and her Master of Science in Genetic Counseling from the University of Texas and MD Anderson Cancer Center in Houston, Texas. She is certified by the American Board of Genetic Counselors. Prior to joining Blueprint Genetics in 2022, she worked as a genomic science specialist for Quest Diagnostics in Marlborough, Massachusetts and as a genetic counselor in a hereditary oncology clinic at Scripps Memorial Hospital in La Jolla, California.